(1)
Beyond Glucose: Empagliflozin’s Impact on Fatty Liver in Patients With Type 2 Diabetes; A True Game Changer. IJBR 2025, 3 (2), 193-198. https://doi.org/10.70749/ijbr.v3i2.663.